ReviewJournal of ovarian research2026
Targeting the gut microbiome: an integrated probiotic and prebiotic strategy for polycystic ovary syndrome management.
Review in Journal of ovarian research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Polycystic ovary syndrome (PCOS) is a prevalent endocrine-metabolic disorder in which gut dysbiosis acts as a key environmental driver. This review synthesizes how probiotics and prebiotics remodel the gut ecosystem and ameliorate PCOS through multi-pathway mechanisms:restoring intestinal barrier function, modulating microbial metabolites (e.g., short-chain fatty acids(SCFAs), bile acids(BAs)), attenuating chronic inflammation, and regulating androgen metabolism. We further propose a novel "integrated microbiome‑centric management" framework, demonstrating how microbiota-targeted interventions synergize with dietary, pharmacological, and behavioral strategies to enable personalized, multi-modal PCOS care. This work provides a transformative perspective for translating gut microbiome science into clinical practice across disciplinary boundaries.
Indexed as
Identifiers
42449405What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.